论文部分内容阅读
目的:探讨依帕司他与丹红注射液用于糖尿病周围神经病变治疗中的临床效果。方法:选择我院2015年3月-2016年3月收治的78例糖尿病周围神经病变患者,按照治疗方法不同分为两组。对照组患者接受前列地尔联合丹红注射液治疗,观察组患者行依帕司他与丹红注射液治疗。就两组患者治疗情况进行比较,总结其不良反应发生情况。结果:两组患者治疗效果、不良反应发生率等方面比较差异有统计学意义(p<0.05)。结论:针对糖尿病周围神经病变患者可给予依帕司他与丹红注射液治疗,不但能帮助患者快速改善临床症状,且不良反较少,值得临床推广。
Objective: To investigate the clinical efficacy of epalrestat and Danhong injection in the treatment of diabetic peripheral neuropathy. Methods: 78 patients with diabetic peripheral neuropathy admitted to our hospital from March 2015 to March 2016 were selected and divided into two groups according to the different treatment methods. Patients in the control group received prostaglandin combined with Danhong injection, and patients in the observation group were treated with epalrestat and Danhong injection. The treatment of two groups of patients were compared to summarize the occurrence of adverse reactions. Results: There was significant difference between the two groups in the treatment effect and incidence of adverse reactions (p <0.05). Conclusion: Patients with diabetic peripheral neuropathy can be given epalrestat and Danhong injection treatment, not only can help patients with rapid improvement of clinical symptoms, and adverse reactions less, worthy of clinical promotion.